Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Immunology Market to reach USD 188.08 billion by the end of 2029.

Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

Product Code: HLSDT-77070433
Publish Date: 17-04-2023
Page: 200

Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Immunology is the field of medical and biological research that focuses and studies the immune system. The immune system protects individuals from infection in numerous ways. by enhancing or inhibiting the immune system, immunology medications and substances alter the immunological response. Immunology drugs or agents are used to treat or prevent infections as well as several autoimmune and immunological diseases such type 1 diabetes, rheumatoid arthritis, and psoriatic arthritis. The global market growth is primarily driven by the factors such as a surge in demand for biosimilars, growing awareness about immunological diseases, coupled with the increasing demand for preventive care.

In addition, the rise in incidences of autoimmune disorders is a key factor that is stipulating the market demand in the global market. A study by the National Stem Cell Foundation estimates that at least one of 80 or more autoimmune illnesses affects about 4% of people around the world. For instance, various market participants are focusing on creating and introducing new products to the market as a result of the growing demand for these medications among patients. For instance, Lupin introduced a generic rheumatoid arthritis medication in September 2020. Likewise, As of April 2022, there were approximately 20 pipeline projects from Johnson & Johnson Services, Inc. for a variety of autoimmune indications, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and others, and approximately 30 pipeline projects from Sanofi in the immunology segment. Thereby, the increasing prevalence of autoimmune disorders and growing emphasis on introducing its treatments is boosting the market growth. Moreover, the rising introduction of novel therapies, as well as the increasing product approvals by regulatory agencies are presenting various lucrative opportunities over the forecasting years. However, the high cost of treatment and adverse effects associated with the product are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Immunology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced healthcare infrastructure, along with growing investment on research and development activities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising occurrence of autoimmune conditions, surging demand for preventive care, and increasing drug approvals in the regional market space.

Major market players included in this report are:
AbbVie, Inc.
Janssen Global Services, LLC
Eli Lilly and Company
Novartis AG
Pfizer Inc.
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp.
F. Hoffmann-La Roche Ltd.
Amgen Inc.
Astellas Pharma Inc.

Recent Developments in the Market:
Ø In June 2022, Eli Lilly and Company received the U.S. FDA approval for its OLUMIANT- a first-in-disease systemic treatment that is specially developed for adults with severe alopecia areata (AA), an autoimmune disorder.
Ø In April 2022, AbbVie Inc. received the U.S. FDA approval for its RINVOQ to provide treatment to adult patients with active ankylosing spondylitis.
Ø In March 2022, Pfizer Inc. announced that the company acquired Arena Pharmaceuticals, a company that primarily focuses on advancing innovative potential therapies to cure several immuno-inflammatory diseases. The objective of this acquisition is to expand Pfizer Inc. product portfolio.

Global Immunology Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Monoclonal Antibody
Fusion Proteins
By Disease Indication:
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Immunology Market, by Region, 2019-2029 (USD Billion)
1.2.2. Immunology Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Immunology Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Immunology Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunology Market Dynamics
3.1. Immunology Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increasing incidences of autoimmune disorders Surge in demand for biosimilars
3.1.2. Market Challenges High cost of treatment Adverse effects associated with product
3.1.3. Market Opportunities Rising Introduction of innovative products Increasing product approvals by regulatory agencies
Chapter 4. Global Immunology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Immunology Market, by Drug Class
6.1. Market Snapshot
6.2. Global Immunology Market by Drug Class, Performance – Potential Analysis
6.3. Global Immunology Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Immunology Market, Sub Segment Analysis
6.4.1. Monoclonal Antibody
6.4.2. Immunosuppressants
6.4.3. Fusion Proteins
6.4.4. Others
Chapter 7. Global Immunology Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Immunology Market by Disease Indication, Performance – Potential Analysis
7.3. Global Immunology Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Immunology Market, Sub Segment Analysis
7.4.1. Rheumatoid Arthritis
7.4.2. Psoriatic Arthritis
7.4.3. Plaque Psoriasis
7.4.4. Ankylosing Spondylitis
7.4.5. Inflammatory Bowel Disease
7.4.6. Others
Chapter 8. Global Immunology Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Immunology Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Immunology Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Immunology Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
Chapter 9. Global Immunology Market, Regional Analysis
9.1. Immunology Market, Regional Market Snapshot
9.2. North America Immunology Market
9.2.1. U.S. Immunology Market Drug Class breakdown estimates & forecasts, 2019-2029 Disease Indication breakdown estimates & forecasts, 2019-2029 Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Immunology Market
9.3. Europe Immunology Market Snapshot
9.3.1. U.K. Immunology Market
9.3.2. Germany Immunology Market
9.3.3. France Immunology Market
9.3.4. Spain Immunology Market
9.3.5. Italy Immunology Market
9.3.6. Rest of Europe Immunology Market
9.4. Asia-Pacific Immunology Market Snapshot
9.4.1. China Immunology Market
9.4.2. India Immunology Market
9.4.3. Japan Immunology Market
9.4.4. Australia Immunology Market
9.4.5. South Korea Immunology Market
9.4.6. Rest of Asia Pacific Immunology Market
9.5. Latin America Immunology Market Snapshot
9.5.1. Brazil Immunology Market
9.5.2. Mexico Immunology Market
9.5.3. Rest of Latin America Immunology Market
9.6. Rest of The World Immunology Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie, Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.2.2. Janssen Global Services, LLC
10.2.3. Eli Lilly and Company
10.2.4. Novartis AG
10.2.5. Pfizer Inc.
10.2.6. Bristol-Myers Squibb Company
10.2.7. Merck Sharp & Dohme Corp.
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. Amgen Inc.
10.2.10. Astellas Pharma Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now